These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 2003737
1. [Malignancy-associated hypercalcemia]. Yamaguchi K. Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737 [Abstract] [Full Text] [Related]
2. A novel parathyroid hormone-related protein: role in pathology and physiology. Martin TJ, Ebeling PR. Prog Clin Biol Res; 1990 Mar; 332():1-37. PubMed ID: 2184438 [Abstract] [Full Text] [Related]
3. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein. Insogna KL. Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773 [Abstract] [Full Text] [Related]
4. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E. Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357 [Abstract] [Full Text] [Related]
5. Hypercalcemia of malignancy--new insights into an old syndrome. Esbrit P. Clin Lab; 2001 Jun 01; 47(1-2):67-71. PubMed ID: 11214225 [Abstract] [Full Text] [Related]
6. [Malignant humoral hypercalcemia and the parathyroid hormone related protein]. Jemtland R, Rian E, Gautvik KM. Tidsskr Nor Laegeforen; 1991 May 30; 111(14):1738-42. PubMed ID: 2063384 [Abstract] [Full Text] [Related]
7. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia]. Okazaki R. Clin Calcium; 2010 Oct 30; 20(10):1497-502. PubMed ID: 20890031 [Abstract] [Full Text] [Related]
12. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF. J Clin Endocrinol Metab; 2001 Apr 30; 86(4):1525-31. PubMed ID: 11297578 [Abstract] [Full Text] [Related]
13. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA. Curr Opin Endocrinol Diabetes Obes; 2011 Dec 30; 18(6):339-46. PubMed ID: 21897221 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA. Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449 [Abstract] [Full Text] [Related]
15. [PTHrP and breast cancer]. Devys A, Lortholary A, Audran M. Bull Cancer; 2001 Nov 01; 88(11):1075-80. PubMed ID: 11741801 [Abstract] [Full Text] [Related]
17. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM). Kobayashi N, Higurashi T, Iida H, Mawatari H, Endo H, Nozaki Y, Tomimoto A, Yoneda K, Akiyama T, Fujita K, Takahashi H, Yoneda M, Inamori M, Abe Y, Kirikoshi H, Kubota K, Saito S, Ueno N, Nakajima A, Yamanaka S, Inayama Y. J Hepatobiliary Pancreat Surg; 2008 Nov 01; 15(5):531-5. PubMed ID: 18836809 [Abstract] [Full Text] [Related]